100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Our Recommendation
Valclovir 500mg Tablet 10s
2,218+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Herpes labialis / Genital herpes infection / Herpes zoster
Customers also bought
More About Valcosign 500 Tablet
Benefits
In Herpes labialis : Herpes labialis, commonly known as cold sores, is a viral infection that primarily affects the lip. Symptoms typically include a burning pain followed by small blisters or sores. The first attack may also be accompanied by fever, sore throat, and enlarged lymph nodes. Valcosign 500 Tablet can speed up the healing of herpes labialis and also prevent recurrence of the sores. In Genital herpes infection Genital herpes infection is a common sexually transmitted infection marked by genital pain and sores. It can affect both men and women. Symptoms include pain, itching, and irritation. Valcosign 500 Tablet helps in treating the symptoms effectively and also prevents the multiplication of the infection-causing virus.In Herpes zoster
Side Effects
Side effects of Valcosign Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Valcosign Headache Nausea Abdominal pain Dizziness Vomiting Itching Diarrhea
How to use
How to use Valcosign Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Valcosign 500 Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
How Valcosign Tablet works Valcosign 500 Tablet is an antiviral medication. It prevents the multiplication of virus in human cells. This stops the virus from producing new viruses and clears up your infection.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Valcosign 500 Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Valcosign 500 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Valcosign 500 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Valcosign 500 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Valcosign 500 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Valcosign 500 Tablet may be needed. Doctor consultation is advised.Drink plenty of water while you are taking this medicine to lower the side effects on the kidney.
Valcosign 500 Tablet is safe to use in patients with liver disease. No dose adjustment of Valcosign 500 Tablet is recommended.
What if I forget to take it?
If a dose of Valcosign 500 Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
308, T.V. Industrial Estate, S.K. Ahire Marg, Behind Glaxo Lab, Worli, Mumbai 400 030
References
Acosta EP, Flexner C. Antiviral Agents (Nonretroviral). In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1594-600
Safrin S. Antiviral Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 847
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1446-47
Valacyclovir hydrochloride. Research Triangle Park, North Carolina: GlaxoSmithKline; 1995 (19 Jun. 2019)
Valaciclovir hydrochloride. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2011 (24 Jan. 2019)
Valaciclovir. Burgos, Spain: Glaxo Wellcome, S.A.; 2014 (19 Jun. 2019)
Mayo Clinic. Valacyclovir (01 Apr. 2019)
European Medicine Agency. Questions and answers on Valtrex and associated names (valaciclovir, 250, 500 and 1000 mg tablets); 2010 (19 Jun. 2019)
Central Drugs Standard Control Organisation (CDSCO) (01 Apr. 2019)
CiplaMed. Valacyclovir Hydrochloride (20 Feb. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
